(ASIX) AdvanSix - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00773T1016
ASIX: Polymer Resins, Fertilizers, Acetone, Intermediate Chemicals
AdvanSix Inc. (NYSE: ASIX) is a leading specialty chemical company that produces and markets a diverse portfolio of polymer resins and intermediate chemicals. Headquartered in Parsippany, New Jersey, the company was incorporated in 2016 and has established itself as a key player in the production of Nylon 6, a versatile polymer resin used across various industries. Nylon 6 is integral to manufacturing fibers, filaments, engineered plastics, and films, serving applications in automotive, consumer goods, and industrial sectors. Beyond Nylon 6, AdvanSix produces caprolactam, a critical precursor for polymer resins, and ammonium sulfate fertilizers, which are essential for agricultural productivity.
The company’s product range extends to acetone, a solvent used in adhesives, paints, and coatings, as well as other intermediate chemicals such as phenol, cyclohexanone, and sulfuric acid. These chemicals are pivotal in the production of engineered plastics, solvents, and herbicides. AdvanSix markets its products under well-known brands like Aegis, Capran, Sulf-N, Nadone, Naxol, and EZ-Blox, reflecting its commitment to quality and innovation. The company’s distribution network includes direct sales and partnerships with distributors, ensuring a robust supply chain to meet global demand.
From a financial perspective, AdvanSix operates with a market capitalization of $795.96 million, reflecting its mid-sized presence in the commodity chemicals sector. Its trailing P/E ratio of 18.38 indicates a moderate valuation relative to earnings, while the price-to-book ratio of 1.02 suggests that investors are valuing the company closely to its book value. The price-to-sales ratio of 0.52 highlights a relatively low valuation compared to its revenue, potentially signaling undervaluation. However, the return on equity of 5.70% points to modest profitability relative to shareholder equity.
Looking ahead, AdvanSix’s future outlook hinges on its ability to navigate the cyclical nature of the chemical industry while capitalizing on growth opportunities in specialized polymers and agricultural chemicals. The company’s diversified product portfolio provides a degree of resilience against market volatility. However, the trajectory of Nylon 6 demand, particularly in automotive and industrial applications, will be a key driver of future performance. Additionally, AdvanSix’s ability to optimize its supply chain and invest in innovation will be critical in maintaining its competitive edge in a rapidly evolving industry. The company’s focus on operational efficiency and strategic investments in high-margin products could position it for sustained growth, though it must also contend with rising competition and potential margin pressures from fluctuating raw material costs.
Additional Sources for ASIX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ASIX Stock Overview
Market Cap in USD | 714m |
Sector | Basic Materials |
Industry | Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception | 2016-10-03 |
ASIX Stock Ratings
Growth 5y | 46.5% |
Fundamental | -13.8% |
Dividend | 66.5% |
Rel. Strength Industry | -6.37 |
Analysts | 4/5 |
Fair Price Momentum | 21.83 USD |
Fair Price DCF | 31.14 USD |
ASIX Dividends
Dividend Yield 12m | 1.87% |
Yield on Cost 5y | 4.18% |
Annual Growth 5y | 50.42% |
Payout Consistency | 100.0% |
ASIX Growth Ratios
Growth Correlation 3m | -33.5% |
Growth Correlation 12m | 63.8% |
Growth Correlation 5y | 22.3% |
CAGR 5y | 15.46% |
CAGR/Max DD 5y | 0.25 |
Sharpe Ratio 12m | -0.37 |
Alpha | -20.79 |
Beta | 1.30 |
Volatility | 42.02% |
Current Volume | 129k |
Average Volume 20d | 163.1k |
As of March 14, 2025, the stock is trading at USD 23.56 with a total of 128,981 shares traded.
Over the past week, the price has changed by -11.25%, over one month by -20.27%, over three months by -23.41% and over the past year by -11.32%.
Neither. Based on ValueRay Fundamental Analyses, AdvanSix is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -13.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ASIX as of March 2025 is 21.83. This means that ASIX is currently overvalued and has a potential downside of -7.34%.
AdvanSix has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy ASIX.
- Strong Buy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ASIX AdvanSix will be worth about 24.4 in March 2026. The stock is currently trading at 23.56. This means that the stock has a potential upside of +3.61%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 39.5 | 67.7% |
Analysts Target Price | 37.5 | 59.2% |
ValueRay Target Price | 24.4 | 3.6% |